Table 1.
Effectiveness of treatment with autovaccine and polyvalent bacterial lysate in reducing bacterial count of pathogens colonizing the upper respiratory tract mucosa.
| Bacterial species | Intervention | 1st examination – mean bacterial count grade 1–5 (SD) | 2nd examination – mean bacterial count grade 1–5 (SD) | Statistics |
|---|---|---|---|---|
| Staphylococcus aureus (MRSA*) | PBL** | 4.2 (1.6) | 4.1 (2.1) | NS*** |
| Autovaccine | 4.3 (1.1) | 4.2 (1.5) | NS*** | |
| Controls | 4.2 (2.0) | 4.5 (2.1) | NS*** | |
| Haemophilus influenzae | PBL** | 3.8 (1.2) | 1.9 (0.8) | p<0.01 |
| Autovaccine | 4.1 (2.5) | 4.2 (1.9) | NS*** | |
| Controls | 3.6 (2.1) | 3.8 (2.1) | NS*** | |
| Streptococcus pneumoniae | PBL** | 4.3 (1.8) | 2.2 (1.4) | p<0.01 |
| Autovaccine | 4.2 (3.6) | 1.1 (0.3) | p<0.001 | |
| Controls | 4.8 (3.1) | 4.8 (4.2) | NS*** | |
| β-haemolytic streptococci | PBL** | 4.6 (3.3) | 4.5 (1.8) | NS*** |
| Autovaccine | 4.6 (1.1) | 1.7 (1.0) | p<0.01 | |
| Controls | 4.2 (2.7) | 4.3 (1.7) | NS*** |
*
MRSA – methicillin-resistant Staphylococcus aureus;
**
PBL – polyvalent bacterial lysate;
***
NS – no statistical significance.